GACI Life Expectancy and Survival Rate

When a family receives a diagnosis of Generalized Arterial Calcification of Infancy (GACI), one of the first questions that comes to mind is: What does this mean for my child’s future? While the condition is extremely rare and complex, ongoing research and advances in treatment are helping to bring clarity and hope.

This page is designed to provide information about GACI life expectancy and GACI survival rates, while also highlighting the importance of early diagnosis, ongoing medical care, and continued research.

What Impacts GACI Life Expectancy?

Life expectancy for infants and children with GACI varies greatly depending on several factors:

  • Timing of Diagnosis – Early detection can make a critical difference. When GACI is diagnosed during pregnancy or soon after birth, treatment may begin right away, giving children a better chance at survival.
  • Genetic Variants – GACI is often linked to mutations in the ENPP1 or ABCC6 genes. The exact mutation can influence how the condition presents, and in some cases, how severe it becomes.
  • Treatment Response – The use of medications such as bisphosphonates, along with supportive therapies, has improved outcomes for some children.  Research and clinical experience suggest that bisphosphonate treatment for GACI should ideally begin within the first 7 days of life to be most effective in reducing arterial calcification and improving outcomes.
  • Emerging Therapies – A new treatment currently in clinical trials is offering new hope for improved survival rates.
  • Secondary Conditions – Many children who survive GACI may later develop autosomal recessive hypophosphatemic rickets type 2 (ARHR2), which can affect growth, bone development, and mobility. Managing these complications also plays a role in long-term health.

Current GACI Survival Rate

Historically, GACI carried a very poor prognosis, with only 5%-15% of babies surviving past infancy. Survival rates have improved, with about 50% of affected infants now surviving beyond their first year. This statistic reflects the seriousness of the condition but also underscores why awareness, early intervention, and continued research are so essential.

Today, however, survival rates are improving thanks to:

  • Earlier diagnosis through prenatal and genetic testing
  • Increased medical knowledge among specialists
  • Use of new treatments and therapies
  • Support from organizations like Brighter Hope Foundation, which fund research and connect families worldwide

While the low GACI survival rates can sound overwhelming, they don’t tell the full story. Many children diagnosed with GACI do survive, grow, and thrive into childhood and adulthood with proper medical care.

Living Beyond the Diagnosis

Families who receive a GACI diagnosis often feel isolated at first. But you are not alone. Every year, more children survive and go on to live meaningful lives, even while managing ongoing medical challenges.

Parents and caregivers often share that while the diagnosis initially brought fear, it also led them to a strong community of support. Connecting with other families and organizations like Brighter Hope Foundation can help parents find not only medical guidance but also encouragement and hope.

Continued research is essential to improving outcomes and increasing survival rates. Current studies are focused on:

  • Better understanding the genetic causes of GACI
  • Identifying which treatments lead to the best long-term results
  • Exploring new therapies to prevent complications like ARHR2
  • Supporting families with better resources and care guidelines

By raising awareness and funding, we can continue to change what GACI life expectancy means for future generations.

Support for Families

If your child has recently been diagnosed with GACI, know that there are resources available:

  • Visit our What is GACI page to learn more about the condition.
  • Connect with families through our support networks.
  • Explore our research initiatives to see how your involvement can make a difference.

While GACI life expectancy can be difficult to discuss, it is not a fixed outcome. At one stage, only 5%-15% of patients survived, but the GACI survival rate has already improved to around 50% thanks to advances in research and treatment., With continued awareness, hope for the future continues to grow.

Check out additional GACI resources here.